Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Prepaid Assets (2016 - 2025)

Cardiff Oncology's Prepaid Assets history spans 15 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 35.23% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 35.23%, while the annual FY2025 figure was $1.6 million, 35.23% down from the prior year.
  • Prepaid Assets for Q4 2025 was $1.6 million at Cardiff Oncology, up from $956000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $6.0 million in Q1 2022 and bottomed at $956000.0 in Q3 2025.
  • The 5-year median for Prepaid Assets is $2.5 million (2021), against an average of $3.0 million.
  • The largest annual shift saw Prepaid Assets surged 205.07% in 2021 before it crashed 56.14% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $4.8 million in 2021, then grew by 9.96% to $5.2 million in 2022, then plummeted by 56.14% to $2.3 million in 2023, then increased by 10.17% to $2.5 million in 2024, then plummeted by 35.23% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Prepaid Assets are $1.6 million (Q4 2025), $956000.0 (Q3 2025), and $2.2 million (Q2 2025).